Not all people with CLL require therapy. In spite of all current improvements, the iwCLL continue to recommends watchful observation for patients with asymptomatic disorder.86 This suggestion is based on no less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). MPO777 menyediakan https://juliog282rbv3.wikievia.com/user